Cooperative Agreement R13FD006615

This Project Grant award of $466,500.00 from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), aims to develop near-infrared chemiluminescent and fluorescent (NIR CFL) chitosan-based nanoparticles (CNPs) to improve the detection of micrometastatic cancer and guide image-guided surgery. The nanoparticles can be activated by body heat and stored at low temperatures for convenience and safety. The research...

This National Science Foundation (NSF) Computer and Information Science and Engineering (CISE) Federal Grant Program (CFDA 47.070) award of $1,200,000 provides funding to the University of California, Berkeley from October 1, 2024 to September 30, 2028 to develop innovative sensing technologies that integrate DNA nanotechnology and CMOS electronics for next-generation diagnostics. The key objectives of this project grant are to: (1) develop molecular engineering techniques using DNA origami...

The National Science Foundation (NSF) awarded a three-year, $449,999 Project Grant under their Engineering program (CFDA 47.041) to the University of Cincinnati to develop an implantable biosensor platform that can continuously monitor various biomarkers in the body for over a year. The project aims to create a new class of long-lasting aptamer-based sensors protected by robust porous oxide coatings, which would enable the first practical implantable monitoring system for managing chronic...

The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded a $359,995 Project Grant under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program to Clemson University. The funding supports the development and validation of a novel X-ray visualized immunosensor (X-VIS) that can be attached to implanted medical devices to detect and monitor local infection biomarkers. The project aims to fabricate a...

Award Summary Nanoengineering Corporation received $349,909 in Project Grant funding from the National Center for Advancing Translational Sciences (NCATS, CFDA 93.350) for the period July 1, 2025 through June 30, 2026. The award supports commercialization of a viral vector sizing tool called NanoRanger, a portable benchtop instrument designed to measure adeno-associated virus (AAV) capsid sizes at angstrom-scale resolution using proprietary electrospray differential mobility analysis (ES-DMA)...

This CAREER award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) funds the development of an artificial nervous system enabling in-body communication between wearable and implantable bioelectronic devices. Awarded to Georgia TECH Research Corp on June 15, 2025, with $499,896 obligated through May 31, 2030, the project addresses critical limitations in existing therapeutic systems by creating optimized emitter and receiver networks that facilitate real-time...

This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program, is focused on the development of a novel mammalian cell-based nano-biological coating for implantable medical devices. The goal is to address the critical health and economic burden associated with implant-related infections by reducing or eliminating them through the use of this biocompatible and antimicrobial nano-biological coating. The $305,000...

This Project Grant award of $300,000.00 from the National Science Foundation's Division of Information and Intelligent Systems will fund a collaborative research effort led by Florida International University (FIU) to develop AI-driven RFID sensing techniques for smart health applications. The project aims to create more affordable, comfortable, and accessible health monitoring systems by leveraging advances in the Internet of Things and machine learning/AI. The research will focus on addressing...

Federal Project Grant Award Summary Nano-Beads Protein Innovations, Inc. received a $620,174 Project Grant award dated September 1, 2025, from the National Institute of Biomedical Imaging and Bioengineering under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award supports development of NANO-AB, an innovative nanoscale biomaterial designed to advance monoclonal antibody (mAb) purification technologies. The project,...

Nano Pharmasolutions, Inc. received a $275,961 Project Grant award from the National Science Foundation Division of Industrial Innovation under the Engineering federal grant program (CFDA 47.041). The grant funds the development of a novel nanoformulation drug delivery platform to address challenges associated with poorly soluble drugs. The goal is to improve drug solubility and bioavailability through innovative formulation approaches. The one-year project period runs from August 1, 2021...